Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it seems less effective than injectable drugs
Več na: https://www.newscientist.com/article/2505147-daily-pill-could-offer-alternative-to-weight-loss-injections/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home
nazaj
